Table 2 3-year follow-up results of PVP group and PKRP group.
12 months | 24 months | 36 months | |||||||
|---|---|---|---|---|---|---|---|---|---|
PVP (n = 60) | PKRP (n = 60) | P value | PVP (n = 60) | PKRP (n = 60) | P value | PVP (n = 60) | PKRP (n = 60) | P value | |
IPSS | 5.27 ± 1.28 | 5.00 ± 0.82 | 0.397 | 5.68 ± 1.31 | 5.60 ± 0.91 | 0.686 | 6.05 ± 1.29 | 5.75 ± 1.07 | 0.169 |
QoL | 1.55 ± 0.59 | 1.62 ± 0.58 | 0.537 | 1.82 ± 0.75 | 1.73 ± 0.58 | 0.496 | 1.83 ± 0.81 | 1.73 ± 0.55 | 0.428 |
Qmax (ml/s) | 21.45 ± 4.75 | 21.57 ± 3.74 | 0.881 | 20.47 ± 4.63 | 20.52 ± 3.91 | 0.949 | 18.58 ± 4.19 | 18.82 ± 4.52 | 0.770 |
PVR (ml) | 22.88 ± 9.39 | 21.83 ± 5.30 | 0.452 | 24.38 ± 7.70 | 22.78 ± 6.80 | 0.362 | 25.57 ± 12.38 | 23.88 ± 7.92 | 0.377 |